| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 07/24/1997 | WO1997026336A1 Compositions for treating anemia |
| 07/24/1997 | WO1997026331A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 07/24/1997 | WO1997026328A1 Immunotherapy using cytotoxic t lymphocytes (ctl) |
| 07/24/1997 | WO1997026326A1 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use |
| 07/24/1997 | WO1997026023A1 Wound dressing and apparatus |
| 07/24/1997 | WO1997025999A1 Peptides for altering osteoblast adhesion |
| 07/24/1997 | WO1997025996A1 A pharmaceutical composition for stopping opium addiction and preparation thereof |
| 07/24/1997 | WO1997025995A1 Methods for regenerating scarless skin and compositions used therein |
| 07/24/1997 | WO1997018300A3 Murine model for human carcinoma |
| 07/24/1997 | CA2844461A1 Compositions for treating anemia |
| 07/24/1997 | CA2248638A1 Methods and compositions for inhibiting hexokinase |
| 07/24/1997 | CA2243470A1 Recombinant aav virion for expressing epo in a mammal |
| 07/24/1997 | CA2242911A1 Peptides for altering osteoblast adhesion |
| 07/24/1997 | CA2242376A1 Isolated tyrosinase derived peptides and uses thereof |
| 07/23/1997 | EP0785271A1 Threonyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785265A1 Aspartyl tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785264A1 Lencyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0784693A1 Viral vectors and line for gene therapy |
| 07/23/1997 | EP0784691A1 Adenovirus-derived viral vectors having two therapeutic genes: suicide and immunopotentiating |
| 07/23/1997 | EP0784690A1 Complementary adenoviral vector systems and cell lines |
| 07/23/1997 | EP0784688A1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 07/23/1997 | EP0784682A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 07/23/1997 | EP0784681A1 Method of using a scavenger receptor in the treatment of atherosclerosis |
| 07/23/1997 | EP0784677A1 Inhibitor of stem cell proliferation and uses thereof |
| 07/23/1997 | EP0784676A1 Neutralization of foof allergens by thioredoxin |
| 07/23/1997 | EP0784673A1 A method of selecting pluripotent hematopoietic progenitor cells |
| 07/23/1997 | EP0784633A1 Process for purifying factor viii |
| 07/23/1997 | EP0784632A1 Process for extracting high-purity von willebrand factor |
| 07/23/1997 | EP0784631A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 07/23/1997 | EP0784605A1 Selective process for the deacylation of acylated compounds |
| 07/23/1997 | EP0784488A1 Use of neuregulins as modulators of cellular communication |
| 07/23/1997 | EP0784483A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
| 07/23/1997 | EP0649464B1 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/23/1997 | EP0637957B1 Use of an emulsion containing omega-3 fatty acids to produce a medicament to be parenterally administered for treating inflammatory diseases |
| 07/23/1997 | CN1154855A Tonic medicine-essence of pearl and long-noded pit viper |
| 07/23/1997 | CN1154853A Wind-dispelling ointment and preparation method thereof |
| 07/23/1997 | CN1154846A Method for production of solid tea fungus active medicinal preparation |
| 07/23/1997 | CN1154845A Genetic engineering fungus oral prepration capable of expressing active phenylalanine deaminase |
| 07/23/1997 | CN1154844A Donkey-hide gelatin capsule |
| 07/22/1997 | US5650175 Anti-inflammatory factor, method of isolation, and use |
| 07/22/1997 | US5650164 Process for preparing artificial skin with biocompatible perforated membranes |
| 07/22/1997 | US5650157 Pharmaceutical compositions and methods |
| 07/22/1997 | US5650152 Vaccines for antitumor agents |
| 07/22/1997 | US5650145 Dermatological/cosmetic compositions comprising antifungal and antibacterial compounds and reduction of hair loss therewith |
| 07/22/1997 | US5650137 Cosmetic composition containing a superoxide dismutase and a porphyrin |
| 07/22/1997 | US5649903 Apparatus and methods for generating leukocyte free platelet concentrate |
| 07/22/1997 | CA2024310C Method of producing cholesterol-free egg products with an extended refrigerated shelf life and products produced thereby |
| 07/20/1997 | CA2195291A1 Bioactive substance k93-0711 1-1 and 1-2, and process for production thereof |
| 07/17/1997 | WO1997025426A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 07/17/1997 | WO1997025404A1 Disinfecting compositions and processes for disinfecting surfaces |
| 07/17/1997 | WO1997025088A1 Accelerated gas removal from divers' tissues utilizing gas metabolizing bacteria |
| 07/17/1997 | WO1997024929A1 Human g-protein coupled receptor |
| 07/17/1997 | WO1997012220A3 Method for the identification and therapeutic use of disease-associated organisms, elements and forces |
| 07/17/1997 | CA2242411A1 Disinfecting compositions and processes for disinfecting surfaces |
| 07/17/1997 | CA2242340A1 Compositions and methods for the treatment and diagnosis of breast cancer |
| 07/16/1997 | EP0784093A1 Osteoprotegerin |
| 07/16/1997 | EP0783693A1 In vitro models of cns function and dysfunction |
| 07/16/1997 | EP0783585A1 DEFFECTIVE RECOMBINANT ADENOVIRUSES WITH INACTIVATED IVa2 GENE |
| 07/16/1997 | EP0783575A1 Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease |
| 07/16/1997 | EP0783573A1 Method of enhancing expression of mhc class i molecules bearing endogenous peptides |
| 07/16/1997 | EP0783568A1 Fibroblasts for the treatment of muscular disorders |
| 07/16/1997 | EP0783567A1 Human galactokinase gene |
| 07/16/1997 | EP0783511A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 07/16/1997 | EP0783509A1 Human transcription factor iia |
| 07/16/1997 | EP0783314A2 Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards |
| 07/16/1997 | EP0783313A1 Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 07/16/1997 | EP0583281B1 Antivenom immunesera |
| 07/16/1997 | EP0509083B1 Red blood cell storage solution |
| 07/16/1997 | CN1154715A Lactobacillus strains of human origin, their compositions and uses thereof |
| 07/16/1997 | CN1154409A Snake liquor and process for prepn. of same |
| 07/16/1997 | CN1154408A health-care medicated wine made up by using live scorpions as raw material |
| 07/16/1997 | CN1154250A Hair-growth, beauty-care and health-care medicinal liquor, and method for preparing same |
| 07/16/1997 | CN1154248A Traditional Chinese medicine |
| 07/16/1997 | CN1154247A Cooling throat oral liquor |
| 07/16/1997 | CN1154245A Turtle oil, soft-shelled turtle oil and compositions contg. same, and the use thereof |
| 07/15/1997 | US5648478 Tissue-specific enhancer active in prostate |
| 07/15/1997 | US5648455 Treatment of drug resistant bacteria |
| 07/15/1997 | US5648380 Anti-inflammatory wound healing compositions and methods for preparing and using same |
| 07/15/1997 | US5648340 Antitumor |
| 07/15/1997 | US5648226 Isolated peptides derived from tumor rejection antigens, and their use |
| 07/15/1997 | US5648206 Lyophilization of cells |
| 07/15/1997 | US5648099 Cellulose acetate phthalate, polyvinylpyridine |
| 07/15/1997 | US5647985 Whole blood leukodepletion and platelet filter |
| 07/10/1997 | WO1997024443A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 07/10/1997 | WO1997024438A1 Immunostimulatory composition and method |
| 07/10/1997 | WO1997024134A1 A pharmaceutical composition comprising plant worms and muirapuama |
| 07/10/1997 | WO1997024133A1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
| 07/10/1997 | WO1997024132A1 Allogeneic paracrine cytokine tumor vaccines |
| 07/10/1997 | WO1997024130A1 CANCEROUS METASTASIS INHIBITOR COMPRISING SURFACE POLYSACCHARIDE OF STREPTOCOCCUS AGALACTIAE Ia TYPE OR Ib TYPE AS PRINCIPAL COMPONENT |
| 07/10/1997 | WO1997024115A1 Naphthalenecarboxylic acid derivatives |
| 07/10/1997 | WO1997015662A3 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor |
| 07/10/1997 | CA2254791A1 Method for preparation of active substances from nacre, resulting products, useful in medicinal applications |
| 07/10/1997 | CA2241373A1 Compositions and methods for t-cell activation comprising gm-csf and tumor antigen fusion proteins |
| 07/10/1997 | CA2241280A1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 07/10/1997 | CA2240578A1 Receptor specific chimeric viral surface polypeptides for viral and particle incorporation and internalization in target cells |
| 07/10/1997 | CA2240257A1 A pharmaceutical composition comprising plant worms and muirapuama |
| 07/09/1997 | EP0783038A1 Recombinant viral pseudoparticles and their applications as vaccines or as antitumour agents |
| 07/09/1997 | EP0782627A1 Genetically altered t-cells |
| 07/09/1997 | EP0782616A1 Therapeutic grade thrombin production and products |
| 07/09/1997 | EP0782452A1 Cell growth regulator |